| Authors: |
Baravelli CM; Norwegian Porphyria Centre (NAPOS), Department of Medical Biochemistry and Pharmacology, Haukeland University Hospital, Bergen, Norway.; Department of Disease Burden, Norwegian Institute of Public Health, Bergen, Norway., Sandberg S; Norwegian Porphyria Centre (NAPOS), Department of Medical Biochemistry and Pharmacology, Haukeland University Hospital, Bergen, Norway.; Norwegian Organization for Quality Improvement of Laboratory Examinations, Haraldsplass Deaconess Hospital, Bergen, Norway.; Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway., Hammersland MH; Norwegian Porphyria Centre (NAPOS), Department of Medical Biochemistry and Pharmacology, Haukeland University Hospital, Bergen, Norway., Harper P; Department of Medical Biochemistry and Biophysics, Centre for Inherited Metabolic Diseases, Porphyria Centre Sweden, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden., Badminton MN; School of Medicine, Cardiff University, Cardiff, UK., Aguilera P; Department of Dermatology, Hospital Clinic de Barcelona, University of Barcelona, Barcelona, Spain.; Centro de Investigaciones en Red en Enfermedades Raras, CIBER-Er, Madrid, Spain., Cassiman D; Department of Gastroenterology-Hepatology and Metabolic Center, University Hospitals Leuven, Belgium., Deybach JC; Assistance Publique-Hôpitaux de Paris, Centre Français Des Porphyries, Hôpital Louis Mourier, Colombes and INSERM UMR1134, Université Paris Cité, Paris, France., Di Pierro E; Medicine and Metabolic Diseases Unit, Fondazione IRCCS ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Graziadei G; Medicine and Metabolic Diseases Unit, Fondazione IRCCS ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Langendonk JG; Center for Lysosomal and Metabolic Disease, Porphyria Expertise Center Rotterdam, Department of Internal Medicine, Erasmus MC, University Medical Center, Rotterdam, the Netherlands., Marcacci M; Department of Medical and Surgical Sciences for Children and Adults, Internal Medicine Unit, University Hospital of Modena, University of Modena and Reggio Emilia, Modena, Italy., Sardh E; Department of Molecular Medicine and Surgery, Centre for Inherited Metabolic Diseases, Porphyria Centre Sweden, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden., Schmitt C; Assistance Publique-Hôpitaux de Paris, Centre Français Des Porphyries, Hôpital Louis Mourier, Colombes and INSERM UMR1134, Université Paris Cité, Paris, France., To-Figueras J; Department of Dermatology, Hospital Clinic de Barcelona, University of Barcelona, Barcelona, Spain., Ventura P; Department of Medical and Surgical Sciences for Children and Adults, Internal Medicine Unit, University Hospital of Modena, University of Modena and Reggio Emilia, Modena, Italy., Aarsand AK; Norwegian Porphyria Centre (NAPOS), Department of Medical Biochemistry and Pharmacology, Haukeland University Hospital, Bergen, Norway.; Norwegian Organization for Quality Improvement of Laboratory Examinations, Haraldsplass Deaconess Hospital, Bergen, Norway. |
